Author

Wanting Han

Fred Hutch Cancer CenterORCID 0000-0002-2173-3647Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1

Frequent Co-Authors

Peter S. NelsoniD· 2 shared Abhilash BarpandaiD· 1 shared Aidan Winters· 1 shared Arun P. WiitaiD· 1 shared Ashutosh MaheshwariiD· 1 shared Audrey KishishitaiD· 1 shared Becky Xu Hua FuiD· 1 shared Bo HuangiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Peter S. NelsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedJun 23, 2026

Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer

Galina Semenova, Sander B. Frank, Ruth F. Dumpit…·John K. Lee

1 citation

humanproteomics

𝕏 PostBluesky

Cancer BiologyNature GeneticsPeer-reviewedNov 5, 2025

Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator

Haolong Li, James E. Melnyk, Becky Xu Hua Fu…·Felix Yi-Chung Feng

This study uses CRISPR screens to identify PTGES3 as a novel modulator of AR protein levels and function in prostate cancer, showing its role in therapy resistance.

10 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky